Epidemiologic features of human babesiosis in Wisconsin, 1996-2005

Wisconsin Medical Journal

Volumn 106, Issue 4, 2007, Pages 191-195

  Pfeiffer, Christopher D ^a   Kazmierczak, James J ^b   Davis, Jeffrey P ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WISCONSIN DIVISION OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; QUININE; STEROID;

ADULT; AGED; ANAPLASMOSIS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BABESIOSIS; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH SURVEY; HUMAN; LYME DISEASE; MALE; THROMBOCYTOPENIA; TICK BORNE FLAVIVIRUS;

ADULT; AGED; AGED, 80 AND OVER; BABESIOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; WISCONSIN;

EID: 34548214187     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ruebush TK 2nd, Juranek DD, Spielman A, Piesman J, Healy GR. Epidemiology of human babesiosis on Nantucket Island. Am J Trop Med Hyg. 1981;30:937-941.
2. Pruthi RK, Marshall WF, Wiltsie JC, Persing DH. Human babesiosis. Mayo Clin Proc. 1995;70:853-862.
3. Homer MJ, Aguilar-Delfin I, Telford SR, Krause PJ, Persing DH. Babesiosis. Clin Micro Rev. 2000;13:451-469.
4. Kjemtrup AM, Conrad PA. Human babesiosis: an emerging tick-borne disease. Int J Parasitol. 2000;30:1323-1337.
5. Western KA, Benson GD, Gleason NN, Healy GR, Schultz MG. Babesiosis in a Massachusetts resident. N Engl J Med. 1970;283:854-856.
6. Walker DH. Tick-transmitted infections in the United States. Ann Rev Public Health. 1998;19:237-269.
7. Steketee RW, Eckman MR, Burgess EC, et al. Babesiosis in Wisconsin: a new focus of disease transmission associated with the coexistence of Lyme disease. JAMA. 1985;253:2675-2678.
8. Herwaldt BL, Springs FE, Roberts PP, et al. Babesiosis in Wisconsin: a potentially fatal disease. Am J Trop Med Hyg. 1995;53:146-151.
9. Krause PJ, McKay K, Thompson CA, et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis. 2002;34:1184-1191.
10. Mitchell PD, Reed KD, Hofkes JM. Immunoserologic Evidence of Coinfection with Borrelia burgdorferi, Babesia microti, and Human Granulocytic Ehrlichia Species in residents of Wisconsin and Minnesota. J Clin Microbiol. 1996;34:724-727.
11. Wormser GP, Dattwyler RJ, Shapiro ED, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089-1134.
12. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Human granulocytic ehrlichiosis in the Upper Midwest United States. JAMA. 1994;272:212-218.
13. Krause PJ, Lepore T, Sikand VK, et al. Atovaquone and azithromycin for the treatment of babesiosis. N Engl J Med. 2000;343:1454-1458.
14. White DJ, Talarico J, Chang HG, Birkhead GS, Heimberger T, Morse DL. Human babesiosis in New York State: review of 139 hospitalized cases and analysis of prognostic factors. Arch Intern Med. 1998;158:2149-2154.
15. Meldrum SC, Birkhead GS, White DJ, Benach JL, Morse DL. Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis. 1992;15:1019-1023.
16. Herwaldt BL, McGovern PC, Gerwel MP, Easton RM, MacGregor RR. Endemic babesiosis in another Eastern state: New Jersey. Emerg Infect Dis. 2003;9:184-188.